Back to search

Italy· 044269037

GHEMAXAN*10 siringhe preriempite 2.000 UI 0,2 ml con sistema di sicurezza

A medicinal product containing enoxaparina sodica, registered in Italy by CHEMI SpA, on the national reimbursement list.

Reimbursed in Italy (AIFA class A)

Checked against the register on

Informational only — not a medical device.

SOURCE REGISTER · ITPublic registernormalisedGHEMAXAN*10 siringhe preriempite 2.00…ATC—REGISTER NO.044269037PACKS LISTED1CHECKEDJune 4, 2026

The record

At a glance

Active substance
Enoxaparina sodica
Manufacturer
CHEMI SpA
Country
Italy (IT)
ATC code
—
Reimbursed
Yes
Last checked
June 4, 2026

Packs & prices · 1

1 priced
  • aic
    044269037
    GHEMAXAN*10 siringhe preriempite 2.000 UI 0,2 ml con sistema di sicurezza
    EUR 22.11

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/de8c79eb-f0bb-4e19-93f1-0f3f6983073d
GET /v1/drugs/de8c79eb-f0bb-4e19-93f1-0f3f6983073d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "price": 22.11,
  "source": "aifa",
  "currency": "EUR",
  "strength": "ENOXAPARINA 2.000UI 10 UNITA' USO PARENTERALE",
  "substance": "Enoxaparina sodica",
  "equivalence_group": "KKQ",
  "transparency_flag": null
}

See everything about enoxaparina sodica.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.